Nephros (NEPH) Net Income towards Common Stockholders (2010 - 2026)

Nephros' Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at $129000.0 for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 77.72% year-over-year to $129000.0; the TTM figure through Mar 2026 stood at $765000.0 (down 8.6% YoY), while the FY2025 annual figure was $1.2 million, up 1513.51% from the prior year.
• Net Income towards Common Stockholders was $129000.0 for Q1 2026 at Nephros, up from $62000.0 in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $579000.0 in Q1 2025 to a low of -$3.2 million in Q3 2022.
• Historically, Net Income towards Common Stockholders has averaged -$443000.0 across 5 years, with a median of -$182000.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders plunged 240.6% in 2022, then surged 428.98% in 2025.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$918000.0 in 2022, then climbed by 28.76% to -$654000.0 in 2023, then jumped by 155.66% to $364000.0 in 2024, then plunged by 82.97% to $62000.0 in 2025, then jumped by 108.06% to $129000.0 in 2026.
• The last three Net Income towards Common Stockholders figures came in at $129000.0 (Q1 2026), $62000.0 (Q4 2025), and $337000.0 (Q3 2025), per Business Quant data.